The pharmaceutical industry is rapidly evolving, with substantial demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a diabetes drug, is a key example of this trend. To meet this demand, US-based manufacturing services are emerging. These providers offer a detailed suite of capabilities, from research and development